Abstract
Colorectal cancer (CRC) is a significant global health concern, requiring effective preclinical models for studying its development and testing therapies. Mouse models have been used, including spontaneous tumors, carcinogen exposure, and tumor cell implantation as xenografts or at orthotopic sites. Here, we describe an orthotopic preclinical model of CRC, which provides a valuable tool for studying tumor growth and the tumor microenvironment, offering a more accurate representation of human CRC compared to xenograft models.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Keum N, Giovannucci E (2019) Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol 16(12):713–732
Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247(4940):322–324
Reitmair AH, Schmits R, Ewel A, Bapat B et al (1995) MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 11(1):64–70. https://doi.org/10.1038/ng0995-64
Su L-K, Kinzler KW, Vogelstein B et al (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256(5057):668–670
Tanaka T, Kohno H, Suzuki R et al (2003) A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 94(11):965–973
Wilmanns C, Fan D, O'Brian CA et al (1992) Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer 52(1):98–104. https://doi.org/10.1002/ijc.2910520118
Chen C, Neumann J, Kühn F, et al (2020) Establishment of an Endoscopy-Guided Minimally Invasive Orthotopic Mouse Model of Colorectal Cancer. Cancers (Basel) 12(10):3007. https://doi.org/10.3390/cancers12103007
Tan MH, Holyoke ED, Goldrosen MH (1977) Murine colon adenocarcinoma: syngeneic orthotopic transplantation and subsequent hepatic metastases. J Natl Cancer Inst 59(5):1537–1544. https://doi.org/10.1093/jnci/59.5.1537
Alencar H, King R, Funovics M et al (2005) A novel mouse model for segmental orthotopic colon cancer. Int J Cancer 117(3):335–339
Céspedes MV, Espina C, GarcÃa-Cabezas MA et al (2007) Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am J Pathol 170(3):1077–1085. https://doi.org/10.2353/ajpath.2007.060773
Yakou MH, Ghilas S, Tran K, et al (2023) TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma. Sci Immunol 8(88): https://doi.org/10.1126/sciimmunol.adf2163
Jacobse J, Pilat JM, Li J et al (2024) Distinct roles for interleukin-23 receptor signaling in regulatory T cells in sporadic and inflammation-associated carcinogenesis. Front. oncol 13 (1276743). https://doi.org/10.3389/fonc.2023.1276743
Zhao X, Li L, Starr TK et al (2017) Tumor location impacts immune response in mouse models of colon cancer. Oncotarget 8(33):54775–54787. https://doi.org/10.18632/oncotarget.18423
Selby MJ, Engelhardt JJ, Johnston RJ et al (2016) Preclinical development of ipilimumab and nivolumab combination immunotherapy: mouse tumor models, in vitro functional studies, and cynomolgus macaque toxicology. PLoS One 11(9):e0161779. https://doi.org/10.1371/journal.pone.0161779
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Yakou, M.H., Afshar-Sterle, S., Ernst, M., Mielke, L.A. (2024). Orthotopic MC-38 Allograft as a Robust Preclinical Model of Colorectal Carcinoma. In: Saad, M.I. (eds) Patient-Derived Xenografts. Methods in Molecular Biology, vol 2806. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3858-3_14
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3858-3_14
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3857-6
Online ISBN: 978-1-0716-3858-3
eBook Packages: Springer Protocols